ZN568_HUMAN - dbPTM
ZN568_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ZN568_HUMAN
UniProt AC Q3ZCX4
Protein Name Zinc finger protein 568
Gene Name ZNF568
Organism Homo sapiens (Human).
Sequence Length 644
Subcellular Localization Nucleus .
Protein Description Has transcriptional repression activity, partially through the recruitment of the corepressor TRIM28 but has also repression activity independently of this interaction. Essential during embryonic development, where it acts as direct repressor of a placental-specific transcript of IGF2 in early development and regulates convergent extension movements required for axis elongation and tissue morphogenesis in all germ layers. Also important for normal morphogenesis of extraembryonic tissues including the yolk sac, extraembryonic mesoderm and placenta. May enhance proliferation or maintenance of neural stem cells..
Protein Sequence MTSQSSVISNSCVTMERLSHMMERKAWCSQESALSEEEEDTTRPLETVTFKDVAVDLTQEEWEQMKPAQRNLYRDVMLENYSNLVTVGCQVTKPDVIFKLEQEEEPWVMEEEMFGRHCPEVWEVDEQIKKQQETLVRKVTSISKKILIKEKVIECKKVAKIFPLSSDIVTSRQSFYDCDSLDKGLEHNLDLLRYEKGCVREKQSNEFGKPFYHCASYVVTPFKCNQCGQDFSHKFDLIRHERIHAGEKPYECKECGKAFSRKENLITHQKIHTGEKPYKCNECGKAFIQMSNLIRHHRIHTGEKPYACKDCWKAFSQKSNLIEHERIHTGEKPYECKECGKSFSQKQNLIEHEKIHTGEKPYACNECGRAFSRMSSVTLHMRSHTGEKPYKCNKCGKAFSQCSVFIIHMRSHTGEKPYVCSECGKAFSQSSSLTVHMRNHTAEKPYECKECGKAFSRKENLITHQKIHTGEKPYECSECGKAFIQMSNLIRHQRIHTGEKPYACTVCGKAFSQKSNLTEHEKIHTGEKPYHCNQCGKAFSQRQNLLEHEKIHTGEKPFKCNECGKAFSRISSLTLHVRSHTGEKPYECNKCGKAFSQCSLLIIHMRSHTGEKPFECNECGKAFSQRASLSIHKRGHTGERHQVY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MTSQSSVIS
------CCCCHHHHH
35.1624043423
3Phosphorylation-----MTSQSSVISN
-----CCCCHHHHHH
27.1124043423
5Phosphorylation---MTSQSSVISNSC
---CCCCHHHHHHHH
26.7524043423
6Phosphorylation--MTSQSSVISNSCV
--CCCCHHHHHHHHH
18.8124043423
9PhosphorylationTSQSSVISNSCVTME
CCCHHHHHHHHHHHH
22.1224043423
11PhosphorylationQSSVISNSCVTMERL
CHHHHHHHHHHHHHH
11.8124043423
14PhosphorylationVISNSCVTMERLSHM
HHHHHHHHHHHHHHH
20.0324043423
19PhosphorylationCVTMERLSHMMERKA
HHHHHHHHHHHHHHH
18.6324043423
35PhosphorylationCSQESALSEEEEDTT
HCCHHHCCCCCCCCC
42.5524719451
74 (in isoform 3)Ubiquitination-32.96-
76 (in isoform 3)Ubiquitination-3.31-
81PhosphorylationRDVMLENYSNLVTVG
HHHHHHCCCCCEEEE
6.9125072903
82PhosphorylationDVMLENYSNLVTVGC
HHHHHCCCCCEEEEC
34.9625072903
86PhosphorylationENYSNLVTVGCQVTK
HCCCCCEEEECEECC
17.8525072903
92PhosphorylationVTVGCQVTKPDVIFK
EEEECEECCCCEEEE
15.8125072903
130AcetylationEVDEQIKKQQETLVR
HHHHHHHHHHHHHHH
59.8620167786
143PhosphorylationVRKVTSISKKILIKE
HHHHHHHCHHHHHCC
27.8822468782
156 (in isoform 3)Phosphorylation-37.1825921289
170PhosphorylationPLSSDIVTSRQSFYD
CCCCCCCCCCCCCCC
20.6522210691
253SumoylationGEKPYECKECGKAFS
CCCCCCCCHHHCCCC
44.06-
253SumoylationGEKPYECKECGKAFS
CCCCCCCCHHHCCCC
44.06-
270UbiquitinationENLITHQKIHTGEKP
HCCCCCCCCCCCCCC
28.93-
273 (in isoform 3)Phosphorylation-50.97-
273PhosphorylationITHQKIHTGEKPYKC
CCCCCCCCCCCCCCC
50.9729496963
278PhosphorylationIHTGEKPYKCNECGK
CCCCCCCCCCCHHHH
38.9618767875
279SumoylationHTGEKPYKCNECGKA
CCCCCCCCCCHHHHH
38.83-
279SumoylationHTGEKPYKCNECGKA
CCCCCCCCCCHHHHH
38.83-
301PhosphorylationIRHHRIHTGEKPYAC
HHHCCCCCCCCCCCC
44.6728111955
314 (in isoform 3)Phosphorylation-5.71-
329PhosphorylationIEHERIHTGEKPYEC
CCCCCCCCCCCCCCC
44.6729496963
337SumoylationGEKPYECKECGKSFS
CCCCCCCCCCCCCCC
44.06-
337SumoylationGEKPYECKECGKSFS
CCCCCCCCCCCCCCC
44.06-
357PhosphorylationIEHEKIHTGEKPYAC
HHHCCCCCCCCCCCC
50.97-
378PhosphorylationFSRMSSVTLHMRSHT
HHHHCCEEEEECCCC
16.9422210691
385PhosphorylationTLHMRSHTGEKPYKC
EEEECCCCCCCCEEC
48.5624719451
430PhosphorylationCGKAFSQSSSLTVHM
CCCCCCCCCCCEEEC
22.2422210691
434PhosphorylationFSQSSSLTVHMRNHT
CCCCCCCEEECCCCC
15.4322210691
449SumoylationAEKPYECKECGKAFS
CCCCEECCCCCCCCC
44.06-
449SumoylationAEKPYECKECGKAFS
CCCCEECCCCCCCCC
44.06-
466UbiquitinationENLITHQKIHTGEKP
HCCCCCCCEECCCCC
28.93-
469PhosphorylationITHQKIHTGEKPYEC
CCCCCEECCCCCCCC
50.9718452278
474PhosphorylationIHTGEKPYECSECGK
EECCCCCCCCCHHHH
40.4129978859
477PhosphorylationGEKPYECSECGKAFI
CCCCCCCCHHHHHHH
24.7929978859
497PhosphorylationIRHQRIHTGEKPYAC
HHHCCCCCCCCCEEE
44.6728111955
525PhosphorylationTEHEKIHTGEKPYHC
CCCCCCCCCCCCCCC
50.97-
553PhosphorylationLEHEKIHTGEKPFKC
HHHCCCCCCCCCEEC
50.9718669648
596PhosphorylationNKCGKAFSQCSLLII
CCCCHHHHHCCEEEE
34.83-
599PhosphorylationGKAFSQCSLLIIHMR
CHHHHHCCEEEEECC
20.69-
612UbiquitinationMRSHTGEKPFECNEC
CCCCCCCCCEECCCC
57.25-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ZN568_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ZN568_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ZN568_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of ZN568_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ZN568_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP